Equity Research Report: Chemfab Alkalis Ltd.
Date: January 28, 2026
Analyst: Gemini (Professional Equity Research Analyst)
Data Sources: Screener.in, BSE Filings, Company Announcements.
Overview
Chemfab Alkalis Ltd. ek established chemical manufacturer hai jo mainly Chlor-Alkali sector me operate karti hai. Company South India based hai aur ab value-added products (PVC-O pipes) ki taraf aggressive expansion kar rahi hai. Hal hi me (January 2026) company ne modernization project complete kiya hai jo efficiency badhane ke liye critical hai.
1️⃣ Business Model & Work
Company ka business model cyclical hai aur predominantly B2B (Business to Business) hai.
- Core Products (Chlor-Alkali):
- Caustic Soda (Lye & Flakes): Textile, alumina, aur paper industries me use hota hai. Yeh revenue ka sabse bada hissa hai.
- Chlorine & Hydrogen: By-products jo industrial applications me bikte hain.
- PVCO Pipes (New Growth Engine): Company ne downstream expansion karte hue PVC-O (Oriented PVC) pipes manufacturing start ki hai, jo water infrastructure aur irrigation me use hoti hain.
- Revenue Mix:
- Domestic: ~99% (India focused).
- Export: Negligible (<1%).
- Competitive Advantage:
- Efficiency Upgrade: Jan 2026 me commission hua naya INEOS Electrolyser purani 30-saal purani technology ko replace karega, jisse power consumption (major cost) drastically kam hogi.
- Location: South India me strong presence jahan industrial chemical demand steady hai.
2️⃣ Industry & Sector Analysis
- Sector Status:Cyclical Downturn (Recovery Expected).
- Chemical sector pichle 1-2 saal se price correction aur oversupply (dumping from China) jhel raha hai.
- Cyclicality: Yeh ek highly cyclical sector hai. Jab Caustic Soda ke prices girte hain (ECU realizations drop), profitability turant hit hoti hai – jo abhi company ke recent numbers me dikh raha hai.
- Growth Drivers:
- Jal Jeevan Mission: Government ke water infrastructure push se PVC-O pipes ki demand strong rehne wali hai.
- Import Restrictions: BIS standards ke chalte cheap imports par rok lagne se domestic players ko fayda hoga.
3️⃣ Latest Financial Performance (Verified Data)
Figures in ₹ Crores (Consolidated)
(Data Source: Screener.in / BSE Filings – Latest available Q2 FY26 & TTM)
| Metric | FY 2024 | FY 2025 | Latest Qtr (Sep ’25) | TTM (Trailing 12M) | Trend |
| Sales (Rev) | 327 Cr | 322 Cr | ~77 Cr | ~320 Cr | 🔻 Flat/Weak |
| Op. Profit | 58 Cr | 54 Cr | ~5.5 Cr | ~42 Cr | 🔻 Declining |
| OPM % | 18% | 17% | ~7% | ~13% | ⚠️ Margin Hit |
| Net Profit | 30 Cr | 15 Cr | (Loss -2.0 Cr) | ~2-3 Cr | 🚨 Severe Drop |
| EPS (₹) | 21.1 | 10.6 | Negative | ~1.5 – 2.0 | 🔻 Bottoming out |
- Analysis:
- Revenue: Topline stagnate ho gayi hai (~₹80 Cr quarterly run-rate).
- Profitability Crash: Latest quarter (Sep 2025) me company ne Loss report kiya hai due to weak chemical prices. Margins 17% se girkar single digit (7%) me aa gaye hain.
- Debt Status: Company ne recent capex (₹57 Cr) internal accruals se fund kiya hai, lekin PVC-O expansion ke liye thoda debt badha hai. Debt/Equity ~0.15 – 0.20 (Still very comfortable).
- Cash Flow: Operations se cash flow positive hai, lekin capex heavy hone ki wajah se Free Cash Flow (FCF) abhi negative ya low hai.
4️⃣ Management & Shareholding (Latest Pattern)
(Data as of Dec 2025 Filing)
- Promoter Holding:~72.13%
- Promoters (Dr. Rao Holdings, Suresh Krishnamurthi) ka stake bahut high hai, jo skin-in-the-game dikhata hai.
- Pledging: 0% (No shares pledged – Clean sign).
- Institutions (FII/DII):
- FII: ~0.08% (Negligible).
- DII: ~0.27% (Negligible).
- Public: ~27.5%.
- Observation: Institutional interest bilkul nahi hai (Micro-cap risk). Stock puri tarah retail aur promoters ke haath me hai.
5️⃣ Valuation (Market Data)
- Current Market Price (CMP): ~₹408 – ₹412
- Market Cap: ~₹580 Crores (Micro-cap)
| Ratio | Current Value | 5-Year Avg | Interpretation |
| Stock PE | ~60x – 100x+ | ~15x | Very Expensive. Due to recent loss/low profit, PE distort ho gaya hai. |
| Price / Book | ~2.5x | ~1.8x | Trading at a premium to book value despite losses. |
| EV / EBITDA | ~18x | ~8x | Expensive compared to historical levels. |
- Fair Value:
- Currently, stock Overvalued zone me lag raha hai agar hum sirf current depressed earnings (TTM) ko dekhein. Market shayad future recovery (FY27) ko price-in kar raha hai.
- Peer Comparison: Gujarat Alkalies aur Chemplast Sanmar bhi struggle kar rahe hain, indicating sector-wide issue, not just company specific.
6️⃣ Future Growth Triggers (1–3 Years)
- Modernization Benefit (Q4 FY26 Onwards):
- Jan 2026 me start hua naya INEOS Electrolyser power consumption kam karega. Since power cost total manufacturing cost ka ~60% hota hai, isse margins me sharp recovery aani chahiye.
- PVC-O Capacity Expansion:
- Company PVC-O pipes ki capacity 14,000 TPA se badhakar 23,000+ TPA kar rahi hai. Ye segment high volume growth de sakta hai infrastructure projects se.
- Captive Power: Solar aur wind hybrid power projects se energy cost further reduce karne ka plan hai.
7️⃣ Present Situation (Current Outlook)
- Current Phase:Pain & Transition.
- Stock apne highs se correct ho chuka hai aur earnings bottom bana rahi hain. Recent quarter ka loss ek negative surprise tha.
- Upcoming Catalyst: Today (Jan 28, 2026) Board meeting hai Q3 results ke liye. Agar management guidance positive deti hai regarding new plant efficiency, to stock bottom-out ho sakta hai.
8️⃣ Risk & Red Flags
- Micro-cap Liquidity: Stock me volumes kam hote hain, sudden buying/selling se price me bada swing aa sakta hai.
- Chemical Prices: Agar Caustic Soda ke prices recover nahi hue, to naye plant ki efficiency ke bawajood profit flat rahega.
- Valuation Trap: High PE (due to low earnings) investors ko confuse kar sakta hai. Recovery priced in hai, agar delay hua to stock price gir sakta hai.
9️⃣ Final Verdict
Summary:
- ✅ Clean Balance Sheet: Low debt even after capex.
- ✅ Promoter Confidence: 72% holding is a strong safety net.
- ✅ Efficiency Boost: New technology will directly improve bottom line from next quarter.
- ❌ Current Financials: Loss-making recently due to cyclical downturn.
- ❌ Valuation: Expensive on current numbers.
Investment Suitability:
- Conservative Investor: ❌ AVOID. (High volatility, micro-cap risk, cyclical downturn).
- Aggressive Investor: ⚠️ WATCHLIST / ACCUMULATE ON DIPS.
- Yeh ek classic “Turnaround Bet” hai. Company ne bura waqt (capex + industry downturn) nikal liya hai. Ab efficiency (new plant) aur volume growth (PVC-O) ka time hai.
Target Strategy:
- Buying Zone: ₹370 – ₹390 (Strong Support).
- Risk Reward: High. Agar cycle turn hoti hai, to profits 2x-3x jump kar sakte hain due to operating leverage.
Disclaimer: Ye article sirf educational purpose ke liye hai. Kisi bhi nivesh se pehle apne Financial Advisor se salah zarur lein.